FDA.reportPublic FDA data

24 HR Cardizem 120 MG Extended Release Oral Tablet

RxCUI
830876
RxNorm name
24 HR Cardizem 120 MG Extended Release Oral Tablet
Display name
24 HR Cardizem 120 MG Extended Release Oral Tablet
Full name
24 HR Cardizem 120 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cardizem LADILTIAZEM HYDROCHLORIDEBausch Health US LLC3e180dc7-c871-4efc-8755-cae882976c8d2025-11-11Warnings, Adverse reactionsExact identifier
rxcui: 830876

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e180dc7-c871-4efc-8755-cae882976c8dCARDIZEM LA 120 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Tablet [Cardizem] [SBD] · 24 HR Cardizem 120 MG Extended Release Oral Tablet [SY] · Cardizem LA 120 MG 24 HR Extended Release Oral Tablet [SY]419These highlights do not include all the information needed to use CARDIZEM LA safely and effectively. See full prescribing information for CARDIZEM LA. CARDIZEM® LA (diltiazem hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 198220251111